logo
Psychology Of Preparation: Why Professionals Skip What Matters Most

Psychology Of Preparation: Why Professionals Skip What Matters Most

Forbes16-05-2025
Roy Ward, President/CEO of PREGAME®.
During my two decades in medical device sales, I witnessed a stark reality that fundamentally changed my perspective on human behavior. Day after day, I observed patients receiving treatments for conditions that could have been mitigated, or even prevented entirely, with proper preparation and preventative care. Even more striking was how universal this pattern appeared, regardless of patients' education, income or awareness of risks.
I also realized this observation isn't limited to healthcare. When my company began researching athletic performance, we discovered that even elite athletes—professionals whose livelihoods depend entirely on their bodies—don't always have as many convenient options or time to spend on warmup protocols as they do on recovery and rehabilitation. In business, I see the same pattern. Companies often invest millions in crisis management while underinvesting in strategic preparation.
The paradox is clear: We consistently underinvest in preparation and a proactive mindset, despite overwhelming evidence of its importance.
I think understanding the psychology behind this tendency is the first step toward creating meaningful change, whether in healthcare, athletics or business leadership.
In athletics, research indicates that over 30% of injuries treated in sports medicine clinics are skeletal muscle injuries, many of which can be prevented through proper warmup and stretching routines. Yet, up to 24% of professional athletes retire due to injuries rather than age or performance decline. This highlights that in many cases, despite proper warmup routines administered by coaches and teams, there's still a psychological factor that's contributing to the gap in preparation.
This pattern mirrors what we see in business, too. Let's look at startups: CB Insights found that 35% of startups fail because they simply don't have product-market fit. They found that's the second biggest reason startups crash and burn. And the frustrating part? This kind of obstacle could be avoided with proper research and preparation up front. Yet so many founders rush ahead without taking the time to really understand who they're building for.
This repeated behavior across domains suggests deeper psychological factors at work. Factors we must understand to create lasting change.
We often prioritize immediate rewards over delayed benefits, a phenomenon psychologists call "temporal discounting." This made perfect evolutionary sense when immediate threats dominated our ancestors' lives, but it can create a significant barrier to preparation in modern contexts.
When an athlete faces the choice between jumping straight into performance (immediate gratification) or spending 20 minutes on a proper warmup (delayed benefit), they often naturally gravitate toward the immediate option. The same mechanism can affect business leaders who choose to address urgent emails rather than engage in strategic planning.
Perhaps the most insidious barrier to preparation is the invisibility of its benefits. When preparation works perfectly, the result often looks like "nothing happened." The athlete who doesn't get injured receives no celebration. The business initiative that unfolds smoothly generates no dramatic stories.
Contrast this with the visible, measurable outcomes of recovery or crisis management. The athlete who returns from injury gets praised for their comeback. The executive who saves a failing project becomes the hero. Our brains often struggle to attribute positive outcomes to preparation because the causal relationship is less obvious.
When you think about it, we've created a weird reward system here—a system where the heroes are the ones who swoop in and fix problems, not those who quietly prevent them from happening in the first place. Reactive measures get all the glory and recognition, while proactive work often goes completely unnoticed.
It's backwards, right? We're celebrating the more expensive, less efficient approach while ignoring the smarter, more cost-effective one.
Perhaps most surprising is how experience can often exacerbate rather than mitigate preparation avoidance. Past success can create a dangerous form of overconfidence. The executive who has successfully led projects thinks, "I know how to do this," just as the veteran athlete believes, "My body knows what to do." This can create a dangerous zone where skill meets complacency, and often with costly consequences.
Understanding these psychological barriers allows us to design more effective approaches to preparation. Rather than relying on willpower or awareness, we may need to redesign the preparation experience itself.
The key insight from my work with athletes is that preparation must become appealing rather than obligatory. That's why I'm focused on transforming warmup from a clinical, tedious requirement into an engaging, confidence-boosting experience that athletes actually want to do.
This approach translates directly to business settings. Forward-thinking organizations can build preparation into their cultures and encourage practices that trigger positive emotions rather than feelings of obligation. I've noticed some companies have created pre-project planning phases designed to make strategic thinking more appealing than reactive tasking.
So here's the challenge: What's the one area in your career or business where you know you should be preparing more, but aren't? Take a minute to identify it, then ask yourself which of these psychological barriers is holding you back. Is it the allure of immediate rewards? The invisible benefits? Or maybe past success has made you overconfident?
Rather than relying solely on willpower, consider how you might redesign your approach. How could you transform preparation from a draining obligation into something that actually energizes and motivates you?
I think the future belongs to those who prepare for it effectively—not just because preparation is logically sound, but because it unleashes a competitive advantage and significant confidence that can enable you to hit your peak performance.
Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Factbox-Healthcare firms see growing activist investor involvement in the past year
Factbox-Healthcare firms see growing activist investor involvement in the past year

Yahoo

time5 minutes ago

  • Yahoo

Factbox-Healthcare firms see growing activist investor involvement in the past year

(Reuters) -Activist investors have targeted major healthcare companies over the past year to push them to improve their performance, with some campaigns only coming to light after announcements of board changes. Below are some notable healthcare companies that came under activist pressure in the last 12 months. MEDTRONIC In August 2025, the medical device maker appointed two new independent directors to its board and created independent committees focused on improving its performance, after Elliott Investment Management took a large stake, making it one of the company's biggest shareholders. AVANTOR Engine Capital targeted the life sciences firm in August 2025, urging it to bring in new board directors, cut costs and even consider a sale. CHARLES RIVER LABORATORIES The contract research firm settled with Elliott Investment Management in May 2025 by agreeing to add four new board directors and launch a strategic review of the business. NOVO NORDISK Activist hedge fund Parvus Asset Management is building a stake in the company, as investors have grown concerned that the Danish drugmaker has lost its first-mover advantage in the lucrative weight-loss drug market, the Financial Times reported in June 2025. Reuters has not independently verified the report. GERRESHEIMER London-based investment fund Asset Value Investors in June 2025 pressed the German medical packaging maker to find ways to restore its market value. AVI, with a 3.5% stake in Gerresheimer, said the company needs a new financial leadership to regain its credibility. ILLUMINA In March 2025, the gene-sequencing maker said activist investor Keith Meister would join its board. HENRY SCHEIN In January, private equity firm KKR built a large stake in the medical and dental supplies distributor and reached a deal to add members to the company's board. Henry Schein was also under pressure from other investors, including Ananym Capital Management. PFIZER Activist hedge fund Starboard Value in October 2024 called for management accountability for the company's underperformance. This month, Starboard increased its holding in the drugmaker to 8.5 million shares, which represented about 0.15% of the outstanding shares as of June end. KENVUE In October 2024, Starboard Value took a significant stake in the Band-Aid maker, criticizing the weak performance of its skin health segment, which houses Neutrogena, Aveeno and other brands. After a proxy battle, the companies reached a deal in early 2025 that gave Starboard CEO Jeffrey Smith and two independent directors board seats. CVS HEALTH In November, CVS Health added Glenview Capital's top boss and three others to its board as part of a deal with the hedge fund. The company had been under pressure from investors, including Glenview, to improve operations after missing financial targets several times due to rising medical costs in its health insurance business. Glenview reduced its stake in the company after CVS posted strong results in May. Sign in to access your portfolio

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health
BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

Yahoo

time5 minutes ago

  • Yahoo

BrainsWay Acquires Minority-Stake in Axis Integrated Mental Health

The Investment is part of BrainsWay's ongoing strategy to acquire minority positions in leading U.S. mental health providers to help them raise awareness for and expand access to transformative care BURLINGTON, Mass. and JERUSALEM, Aug. 20, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) ('BrainsWay' or the 'Company'), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it has entered into a strategic equity financing agreement with Axis Management Company, Inc. ('Axis Integrated Mental Health' or 'Axis'), a management services organization servicing several mental health clinics in Colorado. Under the terms of the agreement, BrainsWay will invest $2.3 million initially, and an additional potential $1 million milestone-based investment, for a minority position in Axis in the form of a preferred, annually compounding security. The agreement also provides for a redemption mechanism relating to the shares. 'Our minority-stake investment in Axis follows our previous investment in Stella, and is part of BrainsWay's broader initiative to accelerate access to and awareness of innovative mental health treatments, including Deep TMS Therapy, while continuing to maintain our core focus on advancing our scientific and technological capabilities to ensure best-in-class support for all our customers. Within this strategy, our investments provide capital injections into high performing healthcare providers, which then allows these businesses to invest in growth drivers and launch new locations,' said Hadar Levy, Chief Executive Officer of BrainsWay. 'We see tremendous opportunities for these healthcare providers to offer expanded services and grow their businesses once they secure the necessary capital.' 'Axis offers a robust clinical services platform and is committed to achieving rapid growth and excellent patient outcomes. We are thrilled to support and collaborate with them as their business continues to scale from a well-respected regional platform to one with a larger footprint, enhancing their delivery of life-changing care to additional patients,' concluded Mr. Levy. 'Our partnership with BrainsWay was born out of a mutual desire to deliver the best cutting-edge mental health treatments to the communities we serve,' stated Chris Perez, Chief Executive Officer of Axis. 'Given the peerless reputation of BrainsWay and its proprietary Deep TMS technology, we realize the value this strategic partnership will provide as we further advance in our mission of putting patients first through our best-in-class support.' About BrainsWay BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit About Axis Axis Integrated Mental Health services its leading mental health practices, which are dedicated to transforming lives through a truly comprehensive, integrative model of care. With a team of board-certified specialists combining modern psychiatry and psychotherapy with advanced treatments including Deep TMS™ and Spravato®, Axis utilizes an evidence-based, holistic therapeutic approach to treat patients, all through a single, coordinated care experience under one roof. For more information, please visit Forward-Looking Statement This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential' or similar words, and also includes any financial guidance and projections contained herein. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. In addition, historical results or conclusions from scientific research and clinical studies do not guarantee that future results would suggest similar conclusions or that historical results referred to herein would be interpreted similarly in light of additional research or otherwise. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: the failure of our investments in management services organizations and/or other clinic-related entities to produce profitable returns; inadequacy of financial resources to meet future capital requirements; changes in technology and market requirements; delays or obstacles in launching and/or successfully completing planned studies and clinical trials; failure to obtain approvals by regulatory agencies on the Company's anticipated timeframe, or at all; inability to retain or attract key employees whose knowledge is essential to the development of Deep TMS products; unforeseen difficulties with Deep TMS products and processes, and/or inability to develop necessary enhancements; unexpected costs related to Deep TMS products; failure to obtain and maintain adequate protection of the Company's intellectual property, including intellectual property licensed to the Company; the potential for product liability; changes in legislation and applicable rules and regulations; unfavorable market perception and acceptance of Deep TMS technology; inadequate or delays in reimbursement from third-party payers, including insurance companies and Medicare; inability to commercialize Deep TMS, including internationally, by the Company or through third-party distributors; product development by competitors; inability to timely develop and introduce new technologies, products and applications, which could cause the actual results or performance of the Company to differ materially from those contemplated in such forward-looking statements. Any forward-looking statement in this press release speaks only as of the date of this press release. The Company undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by any applicable securities laws. More detailed information about the risks and uncertainties affecting the Company is contained under the heading 'Risk Factors' in the Company's filings with the U.S. Securities and Exchange Commission. Contacts: BrainsWay:Ido MaromChief Financial Investors:Brian RitchieLifeSci Advisors LLCbritchie@ in to access your portfolio

Chewy Announces Fiscal Second Quarter 2025 Financial Results Conference Call
Chewy Announces Fiscal Second Quarter 2025 Financial Results Conference Call

Yahoo

time5 minutes ago

  • Yahoo

Chewy Announces Fiscal Second Quarter 2025 Financial Results Conference Call

PLANTATION, Fla., August 20, 2025--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal second quarter 2025 financial results before the market opens on Wednesday, September 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed on the company's investor relations website at and a replay of the conference call will also be available on the company's investor relations website for at least 90 days following the event. Chewy Fiscal Second Quarter 2025 Financial Results Conference CallWhen: Wednesday, September 10, 2025Time: 8:00 am ETLive webcast and replay: Conference call registration: Phone Registration Link About Chewy Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies and prescriptions as a result of our broad selection of high-quality products and services, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch to build brand loyalty and drive repeat purchasing. We seek to continually develop innovative ways for our customers to engage with us, as our websites and mobile applications allow our pet parents to manage their pets' health, wellness, and merchandise needs, while enabling them to conveniently shop for our products. We partner with approximately 3,200 of the best and most trusted brands in the pet industry, and we create and offer our own private brands. Through our websites and mobile applications, we offer our customers approximately 130,000 products and services offerings, to bring what we believe is a high-bar, customer-centric experience to our customers. View source version on Contacts Investor Contact: Natalie Nowakir@ Media Contact: Diane Pelkeydpelkey@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store